Zobrazeno 1 - 10
of 400
pro vyhledávání: '"María, Chaparro"'
Let $\boldsymbol{k}$ be a field of characteristic zero and $A=\boldsymbol{k}[x_{1},...,x_{n}]/I$ with $I=(f_{1},...,f_{k})$ be an affine algebra. We study Nambu-Poisson brackets on $A$ of arity $m\geq 2$, focusing on the case when $m$ is even. We con
Externí odkaz:
http://arxiv.org/abs/2302.01781
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 16, p 8808 (2024)
Inflammatory bowel disease is a chronic inflammatory disease that encompasses entities such as Crohn’s disease and ulcerative colitis. Its incidence has risen in newly industrialised countries over time, turning it into a global disease. Lately, st
Externí odkaz:
https://doaj.org/article/35608b0818e34232b4947d1a0b02d0cd
Autor:
Celia Gómez-Labrador, Elena Ricart, Marisa Iborra, Eva Iglesias, María Dolores Martín-Arranz, Luisa de Castro, Ruth De Francisco, Francisco Javier García-Alonso, Ana Sanahuja, Carla J. Gargallo-Puyuelo, Francisco Mesonero, María José Casanova, Míriam Mañosa, Montserrat Rivero, Marta Calvo, Mónica Sierra-Ausin, Carlos González-Muñoza, Xavier Calvet, Santiago García-López, Jordi Guardiola, Lara Arias García, Lucía Márquez-Mosquera, Ana Gutiérrez, Yamile Zabana, Mercè Navarro-Llavat, Rufo Lorente Poyatos, Marta Piqueras, Leyanira Torrealba, Fernando Bermejo, Ángel Ponferrada-Díaz, José L. Pérez-Calle, Manuel Barreiro-de Acosta, Coral Tejido, José Luis Cabriada, Ignacio Marín-Jiménez, Óscar Roncero, Yolanda Ber, Luis Fernández-Salazar, Blau Camps Aler, Alfredo J. Lucendo, Jordina Llaó, Luis Bujanda, Carmen Muñoz Villafranca, Eugeni Domènech, María Chaparro, Javier P. Gisbert
Publikováno v:
Pharmaceutics, Vol 16, Iss 5, p 629 (2024)
Markers that allow for the selection of tailored treatments for individual patients with inflammatory bowel diseases (IBD) are yet to be identified. Our aim was to describe trends in real-life treatment usage. For this purpose, patients from the ENEI
Externí odkaz:
https://doaj.org/article/07a5bfcf65344f8daf0648e08c7a639c
Publikováno v:
International Journal of Agricultural Sustainability, Vol 20, Iss 7, Pp 1307-1321 (2022)
Many Participatory Guarantee System (PGS) are unsustainable because participatory processes requires time. This research focused on the coordination and implementation of actions to strengthen the PGS of the Red de Mercados Agroecológicos de Bogotá
Externí odkaz:
https://doaj.org/article/849132dcb7734728bd05b2fd0ecd1541
Autor:
Montse Baldan-Martin, Cristina Rubín de Célix, Macarena Orejudo, Lorena Ortega Moreno, Samuel Fernández-Tomé, Irene Soleto, Cristina Ramirez, Ricardo Arroyo, Paloma Fernández, Cecilio Santander, José Andrés Moreno-Monteagudo, María José Casanova, Fernando Casals, Sergio Casabona, Irene Becerro, Juan J. Lozano, Ana M. Aransay, María Chaparro, Javier P. Gisbert
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 21, p 15691 (2023)
Biological therapies only benefit one-third of patients with Crohn’s disease (CD). For this reason, a deeper understanding of the mechanisms by which biologics elicit their effect on intestinal mucosa is needed. Increasing evidence points toward th
Externí odkaz:
https://doaj.org/article/f83f7d7f18df4b6a859293ce39bab831
Autor:
Irene Soleto, Cristina Ramirez, Cristina Gómez, Montse Baldan-Martin, Macarena Orejudo, Jorge Mercado, María Chaparro, Javier P. Gisbert
Publikováno v:
Biomedicines, Vol 11, Iss 10, p 2831 (2023)
Inflammatory bowel disease (IBD) is a chronic condition which includes ulcerative colitis (UC) and Crohn’s disease (CD), the origins of which are not yet fully understood. Both conditions involve an exacerbated immune response in the intestinal tra
Externí odkaz:
https://doaj.org/article/e68184ef47b14ba0b9f119d970c80b3f
Autor:
Sergi Casadó-Llombart, María Velasco-de Andrés, Cristina Català, Alejandra Leyton-Pereira, Rebeca Gutiérrez-Cózar, Belén Suárez, Noelia Armiger, Esther Carreras, Miriam Esteller, Elena Ricart, Ingrid Ordás, Javier P. Gisbert, María Chaparro, María Esteve, Lucía Márquez, David Busquets, Eva Iglesias, Esther García-Planella, María Dolores Martín-Arranz, Juliane Lohmann, C. Korcan Ayata, Jan Hendrik Niess, Pablo Engel, Julián Panés, Azucena Salas, Eugeni Domènech, Francisco Lozano, ENEIDA Project of GETECCU, Alfredo J. Lucendo, Jordi Guardiola, Xavier Calvet, Lorenzo Olivá́n, Marta Piqueras
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Crohn’s disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) resulting from the interaction of multiple environmental, genetic and immunological factors. CD5 and CD6 are paralogs encoding lymphocyte co-receptors involved i
Externí odkaz:
https://doaj.org/article/f8c831491e61476d9916ae833d60eb38
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 12, p 10159 (2023)
Inflammatory bowel diseases (IBDs) are chronic, heterogeneous, and inflammatory conditions mainly affecting the gastrointestinal tract. Currently, endoscopy is the gold standard test for assessing mucosal activity and healing in clinical practice; ho
Externí odkaz:
https://doaj.org/article/8a26f882d57e4cbb9a9c76b4589259a5
Autor:
Laura María Chaparro, Laura Fernanda Neira, Daniel Molina, Diego Rivera-Barrera, Maribel Castañeda, Luis Javier López-Giraldo, Patricia Escobar
Publikováno v:
Materials, Vol 16, Iss 12, p 4402 (2023)
The production of waxes from vegetable oils, such as palm oil, for use as a base material in products for human applications is an alternative to those derived from petroleum and animals. Seven palm oil–derived waxes, called biowaxes (BW1–BW7) in
Externí odkaz:
https://doaj.org/article/124231a06329483aa5041c184e21cb51
Autor:
Rosario Medina-Medina, Eva Iglesias-Flores, Jose M. Benítez, Sandra Marín-Pedrosa, Isabel Salgueiro-Rodríguez, Clara I. Linares, Sandra González-Rubio, Pilar Soto-Escribano, Beatriz Gros, Manuel L. Rodríguez-Perálvarez, José L. Cabriada, María Chaparro, Javier P. Gisbert, Eduardo Chicano-Gálvez, Ignacio Ortea, Gustavo Ferrín, Valle García-Sánchez, Patricia Aguilar-Melero
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 10, p 8695 (2023)
Therapy with anti-tumor necrosis factor (TNF) has dramatically changed the natural history of Crohn’s disease (CD). However, these drugs are not without adverse events, and up to 40% of patients could lose efficacy in the long term. We aimed to ide
Externí odkaz:
https://doaj.org/article/fc826a181fd145d4b5fd4b73a2930031